Parliament

The
Council of Europe member states will launch an inquiry in January 2010 on the
influence of the pharmaceutical companies on the global swine flu campaign,
focusing especially on extent of the pharma‘s industry’s influence on WHO. The
Health Committee of the EU Parliament has unanimously passed a resolution
calling for the inquiry. The step is a long-overdue move to public transparency
of a “Golden Triangle” of drug corruption between WHO, the pharma industry and
academic scientists that has permanently damaged the lives of millions and even
caused death.